tebokan 120 mg
dr. willmar schwabe gmbh & co. kg, nemecko - ginkgo biloba - 06 - psychostimulantia (nootropne lieČ., analeptika)
humira
abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresíva - pozrite si dokument s informáciami o produkte.
benfogamma 50
wörwag pharma gmbh & co. kg, nemecko - vitamín b1, samotný - 86 - vitamina, vitagena
tebokan forte 240 mg
dr. willmar schwabe gmbh & co. kg, nemecko - ginkgo biloba - 06 - psychostimulantia (nootropne lieČ., analeptika)
linola fett Őlbad
dr. august wolff gmbh & co. kg arzneimittel, nemecko - lieky s vazelínou a tukmi - 46 - dermatologica
venclyxto
abbvie deutschland gmbh co. kg - venetoclax - leukémia, lymfocytárna, chronická, b-bunka - antineoplastické činidlá - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastické činidlá - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
ozurdex
abbvie deutschland gmbh & co. kg - dexametazón - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex je indikovaný na liečbu dospelých pacientov s makulárnej edém nasledujúcich buď pobočky sietnice-žily occlusion (brvo) alebo strednej sietnice-žily occlusion (crvo). ozurdex je indikovaný na liečbu dospelých pacientov so zápalom zadným segmente oka prezentovať ako noninfectious uveitis. ozurdex je indikovaný na liečbu dospelých pacientov s zraku v dôsledku diabetickej makulárnej edém (dme), ktorí sú pseudophakic alebo ktorí sa považujú za dostatočne vnímavý, alebo nevhodné pre non-kortikosteroidov terapia.
gabagamma 100
wörwag pharma gmbh & co. kg, nemecko - gabapentín - 21 - antiepileptica, anticonvulsiva
gabagamma 300
wörwag pharma gmbh & co. kg, nemecko - gabapentín - 21 - antiepileptica, anticonvulsiva